Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
41%
Malignant Neoplasm
29%
Overall Survival
26%
Prostate Cancer
24%
Clinical Trial
20%
Glioblastoma
20%
Diseases
19%
Non Small Cell Lung Cancer
17%
Chemoradiotherapy
17%
Pancreas Cancer
17%
Ganglioglioma
17%
Continuous Positive Airway Pressure
16%
Radiosurgery
16%
Lung Cancer
16%
Celiac Plexus
15%
Epidermal Growth Factor Receptor
13%
Stereotactic Body Radiation Therapy
12%
Lung
12%
Metastatic Carcinoma
12%
Biochemical Recurrence
11%
Computer Assisted Tomography
11%
Elderly Patient
11%
Lymph Node
10%
Adjuvant Chemotherapy
10%
Radiation Oncology
10%
Temozolomide
10%
Breast Cancer
9%
Re-Irradiation
9%
Intensity Modulated Radiation Therapy
9%
Radiosensitivity
9%
Cancer Cell
9%
Long Term Survival
9%
Pancreas Adenocarcinoma
9%
Prostate Specific Antigen
9%
Stomach Adenocarcinoma
9%
Hazard Ratio
8%
Androgen Deprivation Therapy
8%
Recurrent Disease
8%
Progression Free Survival
8%
Analgesia
8%
Brain Metastasis
8%
Breathing
7%
Cancer
7%
Radiosensitizer
7%
Immunotherapy
7%
Phase I Trials
7%
Proportional Hazards Model
7%
Hypofractionated Radiotherapy
7%
Image-Guided Intervention
6%
Keyphrases
Radiation Therapy
62%
Radiotherapy
39%
Overall Survival
28%
Radiosurgery
19%
Tumor
17%
Glioblastoma
16%
Continuous Positive Airway Pressure
16%
Radiosensitization
16%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
16%
High-grade Glioma
15%
Celiac Plexus
15%
Pancreatic Cancer
15%
Prostate Cancer
14%
Clinical Outcomes
12%
Long-term Survival
12%
Androgen Deprivation Therapy
12%
Local Control
12%
Prostate-specific Antigen
12%
Biochemical Failure
11%
Cancer Patients
11%
Temozolomide
11%
Prostate
11%
Hazard Ratio
10%
Adjuvant Chemotherapy
10%
Elderly Patients
10%
Re-irradiation
10%
Chemotherapy
10%
Confidence Interval
10%
Neoadjuvant Chemoradiotherapy (nCRT)
9%
Non-small Cell Lung Cancer Patients
9%
Israel
8%
Radiation Oncology
8%
Phase I Trial
8%
Progression-free Survival
8%
Multivariate Analysis
8%
Brain Metastases
8%
Prostate Cancer Patients
8%
Metastatic Colorectal Cancer (mCRC)
8%
Lung Cancer
8%
Pain Management
8%
Radiation Treatment Planning
7%
Ionizing Radiation
7%
Dose Escalation
7%
Single Fraction
7%
Lung
7%
Pathological Stage
7%
Non-small Cell Lung Cancer (NSCLC)
7%
Locally Advanced
7%
Drug Combination
7%
Radiation Dose
7%